Re-ALK
Free
Rating summary
Details about Re
- Released
- Updated
- iOS Version
- Age Rating
- Size
- Devices
- Languages
Features
Developer of Re
- Versions
- Price History
- Description
- FAQ
Version History of Re
1.1.1
January 27, 2023
Bug fixes
1.1
January 26, 2023
Price History of Re
Description of Re
Re-ALK is created to improve the quality of ALK-rearranged Non-Small Cell Lung Cancer management through better practices and patients’ adherence. It is used to give scientific content for both doctors and patients. It also opens a forum of discussion for both patients and doctors. Patients can set reminders for their treatment and report adverse events on a regular basis. Doctors can receive adverse events reports from their patients and track them over time. They can also access decisional algorithms for different treatment lines.
Re: FAQ
Is Re available on iPad devices?
No, Re isn’t iPad-friendly.
Who is behind the development of the Re app?
The Re app was made by Sowlutions Inc..
What is the minimum iOS requirement for Re to function properly?
The app needs iOS 13.0 or later to function properly.
What do users think of the app?
Re has a user rating of 5.
What is the main genre of the Re app?
Medical Is The Primary Genre Of The Re App.
What is the latest version of Re?
The latest Re version released is 1.1.1.
When was the last update for Re released?
The date of the last Re update is September 19, 2024.
When was Re introduced to the market?
The Re app was initially released on April 8, 2023.
What age rating does Re have?
The Re app has a content advisory rating of 17+.
Which languages does Re support?
Re currently features the following languages: English.
Is Re available in Apple Arcade's lineup?
No, Re is not available on Apple Arcade.
Are there in-app purchases available in Re?
No, Re does not offer in-app purchases.
Is Re tailored for Apple Vision Pro compatibility?
Unfortunately, Re is not tailored for compatibility with Apple Vision Pro.
Are there any advertisements in Re?
No, there are no advertisements in Re.
Screenshots of Re
